Literature DB >> 17030249

Mumps resurgence in the United States.

Vikas S Kancherla1, I Celine Hanson.   

Abstract

The recent mumps epidemic in the central United States has generated a large amount of public concern. A total of 2597 mumps cases have been reported in the United States in 11 states since January 1, 2006, representing a marked resurgence of mumps in a single year. The majority of these recent cases have occurred in college students age 18 to 25 years. Most were vaccinated with 2 doses of measles, mumps, and rubella-containing vaccines. Such outbreaks provide an opportunity for clinicians to review the clinical presentation, diagnosis, and morbidity of vaccine-preventable infections and also to review immunologic mechanisms and practice guidelines that might contribute to poor vaccine responses. A review of mumps is provided with discussion of potential mechanisms for vaccine failure.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17030249     DOI: 10.1016/j.jaci.2006.07.033

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  8 in total

1.  Challenges in Interpretation of Diagnostic Test Results in a Mumps Outbreak in a Highly Vaccinated Population.

Authors:  L A Trotz-Williams; N J Mercer; K Paphitis; J M Walters; D Wallace; E Kristjanson; J Gubbay; T Mazzulli
Journal:  Clin Vaccine Immunol       Date:  2017-02-06

2.  Evaluation of the Bio-Rad BioPlex Measles, Mumps, Rubella, and Varicella-Zoster Virus IgG multiplex bead immunoassay.

Authors:  Matthew J Binnicker; Deborah J Jespersen; Leonard O Rollins
Journal:  Clin Vaccine Immunol       Date:  2011-07-27

3.  The F gene of rodent brain-adapted mumps virus is a major determinant of neurovirulence.

Authors:  Ken Lemon; Bertus K Rima; Stephen McQuaid; Ingrid V Allen; W Paul Duprex
Journal:  J Virol       Date:  2007-05-02       Impact factor: 5.103

4.  Human leukocyte antigen and cytokine receptor gene polymorphisms associated with heterogeneous immune responses to mumps viral vaccine.

Authors:  Inna G Ovsyannikova; Robert M Jacobson; Neelam Dhiman; Robert A Vierkant; V Shane Pankratz; Gregory A Poland
Journal:  Pediatrics       Date:  2008-05       Impact factor: 7.124

Review 5.  An overview of vaccinations in HIV.

Authors:  Edgar Turner Overton
Journal:  Curr HIV/AIDS Rep       Date:  2007-08       Impact factor: 5.495

6.  Presumed cases of mumps in pregnancy: clinical and infection control implications.

Authors:  Svjetlana Lozo; Ahmed Ahmed; Edward Chapnick; Mary O'Keefe; Howard Minkoff
Journal:  Infect Dis Obstet Gynecol       Date:  2012-02-12

7.  Effects of mumps outbreak in hospital, Chicago, Illinois, USA, 2006.

Authors:  Amanda L Bonebrake; Christina Silkaitis; Gaurav Monga; Amy Galat; Jay Anderson; Joellyn Tiesi Trad; Kenneth Hedley; Nanette Burgess; Teresa R Zembower
Journal:  Emerg Infect Dis       Date:  2010-03       Impact factor: 6.883

8.  Low vaccine efficacy of mumps component among MMR vaccine recipients in Chennai, India.

Authors:  Jeevan Malaiyan; Thangam Menon
Journal:  Indian J Med Res       Date:  2014-05       Impact factor: 2.375

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.